2026May
ZTS May 2026 · strong-buy
Zoetis is a dominant, mature compounder in the animal health space, benefiting from high switching costs, robust brand loyalty, and significant scale economies. With consistent mid-single-digit revenue growth and high operating margins (~37%), it generates strong and predictable free cash flow.Latest published research · analyzed 2026-05-12 · stale · sources unverified